Exact Mass: 875.3735

Exact Mass Matches: 875.3735

Found 20 metabolites which its exact mass value is equals to given mass value 875.3735, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Neuromedin C 1-8

(2R)-2-[(2-Amino-1-hydroxyethylidene)amino]-N-[(1R)-1-{[(1S)-1-{[(1S)-1-{[(1R)-1-[({[(1R)-1-(C-hydroxycarbonimidoyl)-2-(1H-imidazol-5-yl)ethyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]-2-methylpropyl]-C-hydroxycarbonimidoyl}ethyl]-C-hydroxycarbonimidoyl}-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}-2-(1H-imidazol-5-yl)ethyl]butanediimidate

C39H53N15O9 (875.415)


Neuromedin C is a neuropeptide derived from the same precursor polypeptide as neurotensin, and with similar but subtly distinct expression and effect. Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system. Neurotensin was first isolated from extracts of bovine hypothalamus based on its ability to cause a visible vasodilation in the exposed cutaneous regions of anesthetized rats. This structure shows the 1-8 fragment of neuromedin c. Neuromedin C is a neuropeptide derived from the same precursor polypeptide as neurotensin, and with similar but subtly distinct expression and effect

   

Gliadorphin

(2R)-2-({[(2R)-1-[(2S)-2-({[(2S)-1-[(2R)-2-({[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-4-(C-hydroxycarbonimidoyl)butanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-4-(C-hydroxycarbonimidoyl)butanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-phenylpropanoic acid

C43H57N9O11 (875.4177)


Gliadorphin (or gluteomorphin) is a 7-residue opioid peptide (Tyr-Pro-Gln-Pro-Gln-Pro-Phe) derived from the wheat protein gluten. Other related grains such as rye, barley and oats also contain the same sequence of amino acids found in gluten. Gliadorphin is very similar to casomorphin (a casein-derived peptide). Gliadorphin has been verified by mass spectrometry techniques to be present in urine samples of children with autism.

   
   

Dmt-2fluoro-da(bz) amidite

Dmt-2fluoro-da(bz) amidite

C47H51FN7O7P (875.3571)


Dmt-2'fluoro-da(bz) amidite, an uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotide, is a nuclease-resistant antisense compound with high affinity and specificity for RNA targets. Dmt-2'fluoro-da(bz) amidite is also an intermediate for 5’-DMT-3’-phosphoramidite synthesis[1].

   

alpha-Gliadin (43-49)

alpha-Gliadin (43-49)

C43H57N9O11 (875.4177)


   

Diphenoxylate hydrochloride and atropine sulfate

Diphenoxylate hydrochloride and atropine sulfate

C47H58ClN3O9S (875.3582)


   

2’-Fluoro-2’-deoxy-ara-A(Bz)-3’-phosphoramidite

2’-Fluoro-2’-deoxy-ara-A(Bz)-3’-phosphoramidite

C47H51FN7O7P (875.3571)


2’-Fluoro-2’-deoxy-ara-A(Bz)-3’-phosphoramidite is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

   

DMT-locMeC(bz) phosphoramidite

DMT-locMeC(bz) phosphoramidite

C48H54N5O9P (875.3659)


DMT-locMeC(bz) phosphoramidite is a phosphorite monomer that can be used in the synthesis of oligonucleotides.

   

(2s)-2-({[(1s)-1-{[(1s,2s)-2-{1-[(3s)-6-hydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl]-n-methylformamido}-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

(2s)-2-({[(1s)-1-{[(1s,2s)-2-{1-[(3s)-6-hydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl]-n-methylformamido}-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

C41H49N9O11S (875.3272)


   

10-(beta-hydroxybutyryl)-10-beacetylcophalomannine

NA

C47H57NO15 (875.3728)


{"Ingredient_id": "HBIN000073","Ingredient_name": "10-(beta-hydroxybutyryl)-10-beacetylcophalomannine","Alias": "NA","Ingredient_formula": "C47H57NO15","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31163","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

10-(β-hydroxybutyryl)-10-deacetylcophaloman-nine

NA

C47H57NO15 (875.3728)


{"Ingredient_id": "HBIN000076","Ingredient_name": "10-(\u03b2-hydroxybutyryl)-10-deacetylcophaloman-nine","Alias": "NA","Ingredient_formula": "C47H57NO15","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9865","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-[(3s,6s,9z,12s,15s,16r)-3-benzyl-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propylidene]amino}-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

3-[(3s,6s,9z,12s,15s,16r)-3-benzyl-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propylidene]amino}-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

C44H57N7O12 (875.4065)


   

3-[(3s,6r,9z,12s,15s,16r)-3-benzyl-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propylidene]amino}-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

3-[(3s,6r,9z,12s,15s,16r)-3-benzyl-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propylidene]amino}-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

C44H57N7O12 (875.4065)


   

(2r)-2-({3-[(2-{[(2r)-2-{[(2s)-2-{[(2r)-2-[(3-amino-1-hydroxy-4-methyl-7-phenylhept-6-en-1-ylidene)amino]-1,3-dihydroxypropylidene]amino}-1,3-dihydroxybutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxypropylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

(2r)-2-({3-[(2-{[(2r)-2-{[(2s)-2-{[(2r)-2-[(3-amino-1-hydroxy-4-methyl-7-phenylhept-6-en-1-ylidene)amino]-1,3-dihydroxypropylidene]amino}-1,3-dihydroxybutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxypropylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

C44H57N7O12 (875.4065)


   

3-[(9z)-9-ethylidene-5,8,11,14-tetrahydroxy-15-({1-hydroxy-2-[(1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene}amino)-3-(2-methanesulfinylethyl)-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

3-[(9z)-9-ethylidene-5,8,11,14-tetrahydroxy-15-({1-hydroxy-2-[(1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene}amino)-3-(2-methanesulfinylethyl)-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

C40H57N7O13S (875.3735)


   

3-(9-ethylidene-5,8,11,14-tetrahydroxy-15-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-methylbut-2-en-1-ylidene)amino]-3-methylbutylidene}amino)-3-(4-hydroxyphenyl)propylidene]amino}-3-(2-methanesulfinylethyl)-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl)propanoic acid

3-(9-ethylidene-5,8,11,14-tetrahydroxy-15-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-methylbut-2-en-1-ylidene)amino]-3-methylbutylidene}amino)-3-(4-hydroxyphenyl)propylidene]amino}-3-(2-methanesulfinylethyl)-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl)propanoic acid

C40H57N7O13S (875.3735)


   

3-(3-benzyl-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-methylbut-2-en-1-ylidene)amino]-3-methylbutylidene}amino)-3-(4-hydroxyphenyl)propylidene]amino}-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl)propanoic acid

3-(3-benzyl-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-methylbut-2-en-1-ylidene)amino]-3-methylbutylidene}amino)-3-(4-hydroxyphenyl)propylidene]amino}-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl)propanoic acid

C44H57N7O12 (875.4065)


   

(2s)-2-({[(1s)-1-{[(1s,2s)-2-{1-[(3s)-8-hydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl]-n-methylformamido}-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

(2s)-2-({[(1s)-1-{[(1s,2s)-2-{1-[(3s)-8-hydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl]-n-methylformamido}-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

C41H49N9O11S (875.3272)


   

(2s)-2-({[(3s,9s,15r)-12-[(2r)-butan-2-yl]-9-[2-(3-chloro-4-hydroxyphenyl)ethyl]-2,5,11,14-tetrahydroxy-7-methyl-8-oxo-3-(2-phenylethyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-phenylpropanoic acid

(2s)-2-({[(3s,9s,15r)-12-[(2r)-butan-2-yl]-9-[2-(3-chloro-4-hydroxyphenyl)ethyl]-2,5,11,14-tetrahydroxy-7-methyl-8-oxo-3-(2-phenylethyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-phenylpropanoic acid

C45H58ClN7O9 (875.3984)


   

3-[(3s,6r,9z,12s,15s,16r)-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propylidene]amino}-3-(2-methanesulfinylethyl)-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

3-[(3s,6r,9z,12s,15s,16r)-9-ethylidene-5,8,11,14-tetrahydroxy-15-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propylidene]amino}-3-(2-methanesulfinylethyl)-12,16-dimethyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]propanoic acid

C40H57N7O13S (875.3735)